eprintid: 61670 rev_number: 1 eprint_status: archive userid: 1 dir: disk0/00/06/16/70 datestamp: 2026-05-26 15:52:39 lastmod: 2026-05-26 15:52:39 status_changed: 2026-05-26 15:52:39 type: article metadata_visibility: show sword_depositor: 1 creators_name: Alimova, Komila creators_name: Zokirjonova, Muslima creators_name: Musurmonov, Jamoliddin title: ANTIBIOTIKLARGA QARSHI CHIDAMLILIK MUAMMOSI VA YANGI DAVOLASH STRATEGIYALARI ispublished: pub subjects: antibiotiklarga chidamlilik subjects: antimikrob rezistentlik subjects: MRSA subjects: yangi antibiotiklar keywords: antibiotiklarga chidamlilik; antimikrob rezistentlik; MRSA; yangi antibiotiklar note: Imported from Universal Publishings (OAI id oai:ojs.pkp.sfu.ca:article/15686) abstract: Ushbu maqolada zamonaviy tibbiyotning eng dolzarb muammolaridan biri - antibiotiklarga qarshi chidamlilikning kuchayib borishi va undan kelib chiqayotgan epidemiologik, klinik hamda iqtisodiy oqibatlar tahlil qilinadi. Tadqiqotda mikroorganizmlarning antibiotiklarga moslashish mexanizmlari, global miqyosdagi tendensiyalar, shuningdek, infektsiyalarga qarshi yangi davolash strategiyalari ko‘rib chiqiladi. Xususan, fage terapiya, antimikrob peptidlar, CRISPR asosidagi gen yo‘naltirilgan antimikrob yondashuvlar, immunoterapiya va sun’iy intellekt yordamida yaratilayotgan yangi antibiotiklar samaradorligi o‘rganiladi. Maqola ushbu yo‘nalishdagi ilmiy izlanishlar, statistik ma’lumotlar va klinik tajribalar asosida ishlab chiqilgan. Tadqiqot natijalari antibiotiklarga chidamlilikka qarshi kurashda kompleks yondashuv zarurligini ko‘rsatadi. date: 2025-12-25 date_type: published publisher: "Research Science and Innovation house" LLC official_url: https://universalpublishings.com/index.php/jusr/article/view/15686 id_number: oai:ojs.pkp.sfu.ca:article/15686 full_text_status: none publication: Journal of Universal Science Research citation: Alimova, Komila, Zokirjonova, Muslima, Musurmonov, Jamoliddin (2025) ANTIBIOTIKLARGA QARSHI CHIDAMLILIK MUAMMOSI VA YANGI DAVOLASH STRATEGIYALARI. Journal of Universal Science Research.